A Phase 1 Study of AMG 199 in Subjects With MUC17-Positive Gastric and Gastroesophageal Junction Cancer
Condition: Gastric and Gastroesophageal Junction Cancer Intervention: Drug: AMG 199 Sponsor: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Research | Study